About Alcuria Pharma Private Limited
Data last updated:
Alcuria Pharma Private Limited is a private limited company based in Greater Noida, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2019PTC115108. Its GSTIN is 09AASCA0970E1ZJ (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rahul Kumar and Ram Kumar Dixit.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Ram Kumar Sharma S/O Mayaram Khasra No – 382 Haldauni, Greater Noida, Uttar Pradesh, India – 201308.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.51 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹68,390 (net margin 0.5%) and EBITDA of ₹5.88 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 60% over five years.
For more details, the company can be reached via its website alcuriapharma.com.
Company details
Contact details
Alcuria Pharma Private Limited's registered office is in Greater Noida, Uttar Pradesh. Its website is alcuriapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC/O Ram Kumar Sharma S/O Mayaram Khasra No – 382 Haldauni, Greater Noida, Uttar Pradesh, India – 201308
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alcuria Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alcuria Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Alcuria Pharma Private Limited, buy the company report.
Financials of Alcuria Pharma Private Limited
FY 2025 filings availableAlcuria Pharma Private Limited reported revenue of ₹1.51 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 60% over five years, including 21% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68,390 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alcuria Pharma Private Limited, buy the company report.
Board of directors of Alcuria Pharma Private Limited
Alcuria Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Kumar | Director | 19 Nov 2019 | 6 Years 11 Months | Current |
| Ram Kumar Dixit | Director | 27 Mar 2019 | 7 Years 6 Months | Current |
| Gaurav Kumar Parashari | Director | 27 Mar 2019 | 7 Years 6 Months | Current |
Peer comparison
Alcuria Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SRP Adhesives Private Limited | ₹1.52 Cr (FY 2025) | -10.0% | Kanpur, Uttar Pradesh, India | |||
| Parth Formulation Private Limited | ₹1.52 Cr (FY 2024) | -12.0% | Ajmer, Rajasthan, India | |||
| Vivid Biotech (India) Private Limited | ₹1.51 Cr (FY 2024) | -54.0% | New Delhi, Delhi, India | |||
| Cheloor Bio-Pharma & Health Care Limited | ₹1.51 Cr (FY 2025) | 0.0% | Vadapalni, Tamil Nadu, India | |||
| C-Squared Pharma India Private Limited | ₹1.51 Cr (FY 2025) | 56.0% | Mumbai, Maharashtra, India | |||
| Alcuria Pharma Private Limitedthis company | ₹1.51 Cr (FY 2025) | ₹68,390 | 0.5% | 21.0% | Greater Noida, Uttar Pradesh, India | |
| Chandramouli Industries Private Limited | ₹1.51 Cr (FY 2024) | -35.0% | Dhamdha, Chhattisgarh, India | |||
| Welora Lifesciences Private Limited | ₹1.51 Cr (FY 2019) | 842.0% | Chandigarh, India | |||
| Shree Baidyaraj Ayurved Bhawan Private Limited | ₹1.51 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Megs Pharmaceutical Limited | ₹1.51 Cr (FY 2024) | 51.0% | Jaipur, Rajasthan, India | |||
| Perduro (OPC) Private Limited | ₹1.5 Cr (FY 2023) | -85.0% | Chandigarh, India |
To see the full peer comparison of Alcuria Pharma Private Limited, buy the company report.
Auditor
Alcuria Pharma Private Limited is audited by P G M A & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P G M A & ASSOCIATES | FY 2023 | 007865C |
Shareholding
The shareholding of Alcuria Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Alcuria Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alcuria Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alcuria Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alcuria Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AASCA0970E1ZJ | Uttar Pradesh | Active | 09 Apr 2019 |
To see the full GST registrations and return filing status of Alcuria Pharma Private Limited, buy the company report.
Recent activity
Alcuria Pharma Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Rahul Kumar ceased to be Additional Director on 02 Dec 2019.
Frequently asked questions
Alcuria Pharma is an active private limited company based in Greater Noida, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 March 2019 (7+ years old) and is registered under CIN U51909UP2019PTC115108.
Alcuria Pharma has 3 current directors:
- Rahul Kumar - Director
- Ram Kumar Dixit - Director
- Gaurav Kumar Parashari - Director
The latest financial statements of Alcuria Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Alcuria Pharma is 09AASCA0970E1ZJ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Alcuria Pharma is U51909UP2019PTC115108. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alcuria Pharma was incorporated on 27 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Alcuria Pharma by revenue are SRP Adhesives Private Limited, Parth Formulation Private Limited, Vivid Biotech (India) Private Limited, Cheloor Bio-Pharma & Health Care Limited, C-Squared Pharma India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rahul Kumar ceased to be Additional Director on 02 Dec 2019. Rahul Kumar was appointed as Director on 19 Nov 2019. Gaurav Kumar Parashari was appointed as Director on 27 Mar 2019. Alcuria Pharma has 4 board changes on record in total.
Alcuria Pharma can be reached through the website alcuriapharma.com. Its registered office is in Greater Noida, Uttar Pradesh, India.
The registered office of Alcuria Pharma is at CO Ram Kumar Sharma SO Mayaram Khasra No – 382 Haldauni, Greater Noida, Uttar Pradesh, India – 201308.
Alcuria Pharma operates in the pharma industry, in the drug formulation and development segment.